Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
709
-
Total 13F shares, excl. options
-
264M
-
Shares change
-
-17.3M
-
Total reported value, excl. options
-
$12.8B
-
Value change
-
-$861M
-
Put/Call ratio
-
0.73
-
Number of buys
-
284
-
Number of sells
-
-367
-
Price
-
$48.23
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q4 2024
817 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q4 2024.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 709 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 264M shares
of 1.23B outstanding shares and own 21.5% of the company stock.
Largest 10 shareholders include Dodge & Cox (75.2M shares), Fisher Asset Management, LLC (12.5M shares), Invesco Ltd. (12.1M shares), BANK OF AMERICA CORP /DE/ (12M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.8M shares), MORGAN STANLEY (10.1M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (7.7M shares), BlackRock, Inc. (7.69M shares), Boston Partners (5.4M shares), and FMR LLC (4.96M shares).
This table shows the top 709 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.